B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. (33/88)

 (+info)

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. (34/88)

 (+info)

The role of costimulatory molecules in allergic disease and asthma. (35/88)

 (+info)

Costimulatory pathways in multiple sclerosis: distinctive expression of PD-1 and PD-L1 in patients with different patterns of disease. (36/88)

 (+info)

Clinical importance of B7-H3 expression in human pancreatic cancer. (37/88)

 (+info)

Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. (38/88)

 (+info)

Enhancement of effector CD8+ T-cell function by tumour-associated B7-H3 and modulation of its counter-receptor triggering receptor expressed on myeloid cell-like transcript 2 at tumour sites. (39/88)

 (+info)

Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas. (40/88)

 (+info)